LON:BVXP

Bioventix Share Forecast, Price & News

GBX 3,988.32
+8.32 (+0.21 %)
(As of 07/28/2021 04:35 PM ET)
Add
Compare
Today's Range
3,960
4,030
50-Day Range
3,850
4,200
52-Week Range
3,800
4,549.24
Volume8,895 shs
Average Volume5,798 shs
Market Capitalization£207.75 million
P/E Ratio30.40
Dividend Yield2.39%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BVXP News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.


Bioventix logo

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. The company was founded in 2003 and is based in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.98 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Bioventix (LON:BVXP) Frequently Asked Questions

What stocks does MarketBeat like better than Bioventix?

Wall Street analysts have given Bioventix a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bioventix wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Bioventix's earnings last quarter?

Bioventix PLC (LON:BVXP) released its quarterly earnings data on Monday, March, 30th. The biotechnology company reported $69.28 EPS for the quarter.
View Bioventix's earnings history
.

How has Bioventix's stock been impacted by COVID-19?

Bioventix's stock was trading at GBX 3,640 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BVXP shares have increased by 9.6% and is now trading at GBX 3,988.32.
View which stocks have been most impacted by COVID-19
.

How often does Bioventix pay dividends? What is the dividend yield for Bioventix?

Bioventix announced a dividend on Monday, March 29th. Stockholders of record on Thursday, April 8th will be given a dividend of GBX 43 per share on Friday, April 23rd. This represents a yield of 1.03%. The ex-dividend date of this dividend is Thursday, April 8th. The official announcement can be seen at this link.
View Bioventix's dividend history
.

Is Bioventix a good dividend stock?

Bioventix pays an annual dividend of GBX 0.88 per share and currently has a dividend yield of 2.39%. The dividend payout ratio of Bioventix is 0.67%. This payout ratio is at a healthy, sustainable level, below 75%.
View Bioventix's dividend history.

Who are Bioventix's key executives?

Bioventix's management team includes the following people:
  • Mr. Peter John Harrison MA, CEO & Director (Age 63, Pay $269.8k)
  • Mr. Bruce Edward Heath Hiscock B.A., C.A., CFO & Director (Age 63)

Who are some of Bioventix's key competitors?

What other stocks do shareholders of Bioventix own?

What is Bioventix's stock symbol?

Bioventix trades on the London Stock Exchange (LON) under the ticker symbol "BVXP."

How do I buy shares of Bioventix?

Shares of BVXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Bioventix's stock price today?

One share of BVXP stock can currently be purchased for approximately GBX 3,988.32.

How much money does Bioventix make?

Bioventix has a market capitalization of £207.75 million and generates £10.38 million in revenue each year.

How many employees does Bioventix have?

Bioventix employs 12 workers across the globe.

What is Bioventix's official website?

The official website for Bioventix is www.bioventix.com.

Where are Bioventix's headquarters?

Bioventix is headquartered at 7 Romans Business Park, East Street, FARNHAM, GU9 7SX, United Kingdom.

How can I contact Bioventix?

Bioventix's mailing address is 7 Romans Business Park, East Street, FARNHAM, GU9 7SX, United Kingdom. The biotechnology company can be reached via phone at +44-1252-728001.


This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.